Excitatory Amino Acid Antagonists
"Excitatory Amino Acid Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists.
| Descriptor ID |
D018691
|
| MeSH Number(s) |
D27.505.519.625.190.300 D27.505.696.577.190.300
|
| Concept/Terms |
Excitatory Amino Acid Antagonists- Excitatory Amino Acid Antagonists
- Antagonists, Excitatory Amino Acid
- Amino Acids, Excitatory, Antagonists
- Glutamate Receptor Antagonists
- Antagonists, Glutamate Receptor
- Receptor Antagonists, Glutamate
- EAA Antagonists
- Antagonists, EAA
- Glutamate Antagonists
- Antagonists, Glutamate
- Amino Acid Antagonists, Excitatory
|
Below are MeSH descriptors whose meaning is more general than "Excitatory Amino Acid Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Excitatory Amino Acid Antagonists".
This graph shows the total number of publications written about "Excitatory Amino Acid Antagonists" by people in this website by year, and whether "Excitatory Amino Acid Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 2 | 3 |
| 1998 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 2 | 2 |
| 2005 | 1 | 2 | 3 |
| 2006 | 0 | 2 | 2 |
| 2007 | 0 | 1 | 1 |
| 2008 | 3 | 0 | 3 |
| 2010 | 1 | 2 | 3 |
| 2014 | 2 | 0 | 2 |
| 2015 | 1 | 1 | 2 |
| 2016 | 3 | 0 | 3 |
| 2018 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Excitatory Amino Acid Antagonists" by people in Profiles.
-
Mojica JJ, Eddy G, Schwenk ES. N-Methyl-D-aspartate receptor antagonists for the prevention of chronic postsurgical pain: a narrative review. Reg Anesth Pain Med. 2025 02 05; 50(2):160-167.
-
Mohamed LA, Markandaiah SS, Bonanno S, Pasinelli P, Trotti D. Excess glutamate secreted from astrocytes drives upregulation of P-glycoprotein in endothelial cells in amyotrophic lateral sclerosis. Exp Neurol. 2019 06; 316:27-38.
-
Leung JG, Rakocevic DB, Allen ND, Handler EM, Perossa BA, Borreggine KL, Stark AL, Betcher HK, Hosker DK, Minton BA, Braus BR, Dierkhising RA, Philbrick KL. Use of a Gabapentin Protocol for the Management of Alcohol Withdrawal: A Preliminary Experience Expanding From the Consultation-Liaison Psychiatry Service. Psychosomatics. 2018 Sep - Oct; 59(5):496-505.
-
Lauritsen C, Mazuera S, Lipton RB, Ashina S. Intravenous ketamine for subacute treatment of refractory chronic migraine: a case series. J Headache Pain. 2016 Dec; 17(1):106.
-
Friedman LK, Sharma A, Corcia M, Webster T, Qazi L, Simsovits D, Khalil Y, Hu S, Kantrowitz M, Hong H. Selective inhibition of metabotropic glutamate type 1 alpha receptor (mGluR1a) reduces cell proliferation and migration following status epilepticus in early development. Int J Dev Neurosci. 2016 Nov; 54:6-21.
-
Turner J, Mitchell JL, Carroll BT, Denysenko L. Dextromethorphan/quinidine withdrawal-emergent catatonia. Ann Clin Psychiatry. 2016 05; 28(2):138-9.
-
Stocker SD, Lang SM, Simmonds SS, Wenner MM, Farquhar WB. Cerebrospinal Fluid Hypernatremia Elevates Sympathetic Nerve Activity and Blood Pressure via the Rostral Ventrolateral Medulla. Hypertension. 2015 Dec; 66(6):1184-90.
-
Park DB, Hayden GE. Ketamine Saves the Day: Priapism in a Pediatric Psychiatric Patient. Pediatr Emerg Care. 2015 Jul; 31(7):508-10.
-
Paul RK, Singh NS, Khadeer M, Moaddel R, Sanghvi M, Green CE, O'Loughlin K, Torjman MC, Bernier M, Wainer IW. (R,S)-Ketamine metabolites (R,S)-norketamine and (2S,6S)-hydroxynorketamine increase the mammalian target of rapamycin function. Anesthesiology. 2014 Jul; 121(1):149-59.
-
Iglewicz A, Morrison K, Nelesen RA, Zhan T, Iglewicz B, Fairman N, Hirst JM, Irwin SA. Ketamine for the treatment of depression in patients receiving hospice care: a retrospective medical record review of thirty-one cases. Psychosomatics. 2015 Jul-Aug; 56(4):329-37.